🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis Syndrome

RecruitingNAAges 25 Years - 40 YearsAllRiphah International University
NCT07646314 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Piriformis Syndrome (PS) is a condition which is characterized by pain, numbness, and limited range of motion (ROM) due to compression or irritation of the sciatic nerve by the piriformis muscle. It often leads to discomfort in the buttock region, radiating pain along the posterior thigh, and functional limitations in daily activities. Manual therapy techniques, particularly Muscle Energy Techniques (METs), have been widely used for the management of musculoskeletal dysfunctions, including piriformis syndrome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: \- Piriformis syndrome clinically confirmed via special tests (e.g., FAIR test, Freiberg sign, Pace test) * Both gender male and female. * Age between 25 and 40 years. * Presence of antalgic gait due to pain. * Moderate to severe pain (e.g., NPRS score ≥ 4) * Voluntary consent to participate in the study. * Medically stable, no acute or unstable medical conditions that would interfere with participation. Exclusion Criteria: * Lumber disc herniation or radiculopathy confirmed by imaging or neurological signs * History of hip or pelvis surgery. * Other neuromuscular or musculoskeletal disorders e.g., stroke, multiple sclerosis, or rheumatoid arthritis * Recent lower limb fracture or injury within the last 6 months. * Pregnancy due to potential risks and altered biomechanics. * Inability to follow instruction * Ongoing physiotherapy or alternative treatments
💊

What it tests

  • Post isometrics Relaxation Techniques (PIR)
  • Reciprocal Inhibition Technique
📍

Where

1 site
Ghurki Hospital Lahore
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy